About Us
Driving Monoclonal Antibody Innovation with Creative Thinking
Striving to Provide Patients with the Best Possible Treatments
Striving to Provide Patients with the Best Possible Treatments
Genesis Life Science was established in October 2020, focusing on the innovative development of monoclonal antibody (mAb) drugs. The company drives domestic clinical filings and subsequent clinical trial progress, while also carrying out related clinical sample testing. Looking ahead, we aim to achieve the full commercialization of biopharmaceuticals. With our internal research strength and the support of cross-disciplinary expert teams, we are determined to become a leading biopharmaceutical enterprise in China.
We collaborate with external research institutions to license and introduce highly promising monoclonal antibody products. By aligning closely with national key R&D initiatives and urgent market needs, we significantly reduce the time and risks of drug development, thereby accelerating the path to product launch and commercialization.
Caring deeply for human health and patient well-being, we focus on addressing unmet medical needs. Through innovative thinking, we advance monoclonal antibody development and ultimately share our achievements with partners and society, striving to provide patients with the best possible treatment.
美国国家卫生院首席研究员
负责艾滋病治疗
美国华盛顿大学流行病学及医学实验室教授
美国达特茅斯学院微生物及免疫所所长
宾州卓克索大学传染病学教授
主持多项艾滋病临床试验组
首都医科大学附设地坛医院艾滋病诊治和研究中主任
卫生部艾滋病临床专家工作组组长
首都医科大学教授主任医师
北京佑安医院感染科主任
北京协和医院感染内科主任
艾滋病诊疗中心主任
台湾中央研究院院士
奥玛珠单抗共同发明者
UB-221发明者
美国国家卫生院食品过敏研究室资深研究员
复旦大学附属华山医院皮肤科主任
上海市皮肤病医院皮肤内科主任
台大医院皮肤科主治医师
台湾大学医学院皮肤科副教授
深圳市第三人民医院院长
郑州市第六人民医院
感染一科主任
高雄荣总感染管制室主任
高雄荣总感染科主治医师
广东省皮肤病医院院长
亚洲银屑病学会理事
苏北人民医院皮肤科主任医师
江苏省医师协会皮肤性病分会常务委员
四川大学华西医院皮肤性病科副主任医师
江西省皮肤病专科医院中西医结合皮肤科主任
全球银屑病监测项目中国委员会委员
北京友谊医院过敏诊治中心主任
中国医协会皮肤病分会过敏专业委员会副主任委员
From the laboratory to the global stage, our innovative monoclonal antibodies have been repeatedly recognized by leading academic authorities worldwide. Our research is frequently published in top-tier journals such as The New England Journal of Medicine, The Lancet, and Nature, demonstrating our core competitiveness and international influence in the field of monoclonal antibodies. We firmly believe that these science-driven innovations will bring meaningful improvements to patients around the world and mark a new chapter in the history of human medicine.
Genesis Life Science WeChat
Genesis Life Science LinkedIn
ZipCode:222500
Tel.:(0514)82222527
Headquarters (Yangzhou): No.2 Jiankang 1st Road, Yangzhou Hi-Tech Zone,
Hanjiang District, Yangzhou City, Jiangsu Province